date,title,source
Nov-08-18,Entera Bio Reports Positive Results from Part 1 of a Phase 2 PK/PD Study of Oral PTH (1-34) in Patients with Hypoparathyroidism,GlobeNewswire
Dec-11-18,Entera shares jump 11.5% on news of collaboration with Amgen,MarketWatch
Dec-11-18,Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory Disease and Other Serious Illnesses,GlobeNewswire
